• In April 2026, Core Scientific Finance I LLC completed a US$3.30 billion offering of senior secured, guaranteed notes due 2031, alongside Core Scientific Inc.’s push to repurpose its Pecos, Texas site into a roughly 1.5 gigawatt AI-focused data center campus.
• These moves, together with expanded institutional interest and long-term AI infrastructure partnerships, highlight Core Scientific’s accelerating shift away from Bitcoin mining toward high-performance computing and AI hosting.
• Next, we’ll examine how this large secured debt raise and AI data center expansion may reshape Core Scientific’s existing investment narrative.

Find 53 companies with promising cash flow potential yet trading below their fair value.

Core Scientific Investment Narrative Recap

To own Core Scientific today, you have to believe its pivot from Bitcoin mining to AI-focused data centers can offset legacy volatility and execution risk. The new US$3.30 billion secured notes and the Pecos buildout look directly tied to that pivot, but they also increase the stakes by layering on more leverage and execution complexity. In the near term, the key catalyst remains HPC and AI hosting ramping on time, while the biggest risk is still whether that ramp can support the balance sheet.

The most relevant recent announcement here is the planned expansion of the Pecos, Texas campus to roughly 1.5 gigawatts of gross power capacity, with about 1.0 gigawatt available to lease for AI workloads. This is exactly where the new debt is likely to matter most, because investors will be watching how quickly that power is converted into contracted, diversified AI hosting revenue that can complement, and eventually reduce reliance on, the CoreWeave relationship.

Yet beneath this growth story, investors should be aware that customer concentration and higher leverage could combine to...

Core Scientific's narrative projects $1.4 billion revenue and $439.9 million earnings by 2029. This requires 62.4% yearly revenue growth and a $720.6 million earnings increase from -$280.7 million today.

Uncover how Core Scientific's forecasts yield a $26.40 fair value, a 35% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling revenue reaching about US$2.1 billion and earnings near US$962.0 million, which assumes CoreWeave driven growth stays on track, while this new US$3.30 billion financing and AI buildout could either support that vision or magnify the risk that heavy customer concentration becomes a problem; it is a reminder that your own view can reasonably differ a lot from even the most confident forecasts.

Explore 3 other fair value estimates on Core Scientific - why the stock might be worth as much as 82% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Core Scientific research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Core Scientific research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Core Scientific's overall financial health at a glance.

Curious About Other Options?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.